Precipio, Inc. (PRPO)

US — Healthcare Sector
Peers: BDSX  SERA  APDN  OLK  CDNA  CSTL  TWST  NTRA  HTGM  GTH  BIAF  PMD  GENE  MDXH  STRR  XGN  BNR  LMDX 

Automate Your Wheel Strategy on PRPO

With Tiblio's Option Bot, you can configure your own wheel strategy including PRPO - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol PRPO
  • Rev/Share 12.8819
  • Book/Share 7.7849
  • PB 1.413
  • Debt/Equity 0.1849
  • CurrentRatio 0.7569
  • ROIC -0.2154

 

  • MktCap 16632110.0
  • FreeCF/Share 0.4665
  • PFCF 23.7263
  • PE -5.3406
  • Debt/Assets 0.1216
  • DivYield 0
  • ROE -0.2587

 

  • Rating C
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 4
  • D/E Score 2

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

About Precipio, Inc. (PRPO)

  • IPO Date 2017-06-30
  • Website https://www.precipiodx.com
  • Industry Medical - Diagnostics & Research
  • CEO Ilan Danieli
  • Employees 54
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests. It sells ICE-COLD-PCR technology kits to bio-pharma customers. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. The company is based in New Haven, Connecticut.